To determine how the global distribution of these marks varied between KMT2Ar leukemia samples, we first identified regions enriched for each modification in our collection of KMT2Ar leukemia samples as well as CD34+ HSPCs using the SEACR peak-calling method34 and performed PCA to cluster samples according to their modification-specific similarities. Here, CD34 is linked to leukemia.